U.S. markets closed

Akari Therapeutics, Plc (AKTX)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
1.8100-0.0500 (-2.69%)
At close: 4:00PM EDT
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Currency in USD

Valuation Measures

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
 
As of Date: 5/6/2021
Current
12/31/20209/30/20206/30/20203/31/2020
Market Cap (intraday) 5
72.33M71.18M58.93M73.83M41.66M
Enterprise Value 3
58.27M58.86M46.18M68.10M35.93M
Trailing P/E
N/AN/AN/AN/AN/A
Forward P/E 1
N/AN/AN/AN/AN/A
PEG Ratio (5 yr expected) 1
N/AN/AN/AN/AN/A
Price/Sales (ttm)
N/AN/AN/AN/AN/A
Price/Book (mrq)
7.7114.6517.6540.6610.86
Enterprise Value/Revenue 3
N/AN/AN/AN/AN/A
Enterprise Value/EBITDA 7
-3.24-8.54-187.80-11.52-7.30

Trading Information

Stock Price History

Beta (5Y Monthly) 1.15
52-Week Change 3-7.18%
S&P500 52-Week Change 344.45%
52 Week High 34.2100
52 Week Low 31.4200
50-Day Moving Average 32.3653
200-Day Moving Average 32.3201

Share Statistics

Avg Vol (3 month) 3467.54k
Avg Vol (10 day) 3533.84k
Shares Outstanding 538.47M
Implied Shares Outstanding 6N/A
Float 20.63M
% Held by Insiders 128.62%
% Held by Institutions 121.17%
Shares Short (Apr 14, 2021) 471.91k
Short Ratio (Apr 14, 2021) 40.24
Short % of Float (Apr 14, 2021) 4N/A
Short % of Shares Outstanding (Apr 14, 2021) 40.19%
Shares Short (prior month Mar 14, 2021) 484.22k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:10
Last Split Date 3Sep 16, 2015

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2020
Most Recent Quarter (mrq)Dec 30, 2020

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-101.26%
Return on Equity (ttm)-363.75%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -17.07M
Net Income Avi to Common (ttm)-17.08M
Diluted EPS (ttm)-0.5410
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)14.06M
Total Cash Per Share (mrq)0.37
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)2.79
Book Value Per Share (mrq)0.24

Cash Flow Statement

Operating Cash Flow (ttm)-16.95M
Levered Free Cash Flow (ttm)-11.4M